416401
Position
Managing Director, Head of L.E.K. China and Asia Life Sciences
Company
L.E.K. Consulting
Location
Shanghai, CHINA
Bio
Helen Chen is a Managing Director of L.E.K. Consulting based in Shanghai. She is the head of the China office and sat on L.E.K.’s Global Leadership Team, the firm’s governing board, from 2012 to 2016. Helen has over 30 years of consulting and industry experience in the U.S. and Asia, and has resided in China since 2000. Helen is the head of L.E.K.’s China and Asia life sciences practice, with extensive case work and industry experience covering the full biopharmaceutical and medtech value chain, ranging from early research services to post-market product positioning and sales force effectiveness. In China, she has developed commercial strategies for international medtechs, investment thesis for financial investors, business plans for domestic startups and policy analyses for industry associations. Helen produced the 2016 Shanghai government commissioned Chinese outbound investment guide From China to the World: An International Investment and Market Access Guide for Chinese Biopharmaceutical Companies. She is a frequent speaker and author on the opportunities and issues in the China healthcare and life sciences, and has been quoted by publications including BioCentury, BioWorld, In Vivo, Wall Street Journal, Financial Times and Forbes Asia. Prior to joining L.E.K., Helen held senior management roles at a number of technology companies in the U.S. and China. She was an associate director of finance at Genentech and a sales planner at Abbott Laboratories. She is on the organising committee for the Medtronic Sequoia Fund, and was on the Board of Pharmaceutical Management Sciences Association from 1995 to 1997. Helen received her A.B. cum laude in applied mathematics from Harvard University.
Agenda
emergingopp_icon

Emerging Opportunities in Global Markets

11:45 AM–5:00 PM Jun 4, 2018

Room 253ABC, Level 2

Katherine AndersenHead of Healthcare Corporate Finance and East/Central Life Science atSilicon Valley Bank Michael ChanSenior VP atHKEX Helen ChenManaging Director, Head of L.E.K. China and Asia Life Sciences atL.E.K. Consulting Tony ChenPartner atJones Day Shanghei Joseph DamondExecutive Vice President, International Affairs atBiotechnology Innovation Organization Yuan-Hua DingExecutive Director and Head of External Science & Innovation atPfizer Monica H.Director, International Affairs atBiotechnology Innovation Organization Edward HuChief Financial Officer and Chief Investment Officers atWuXi AppTec Kewen JinManaging Partner atSerica Partners Alex JungPartner/Managing DIrector atEY-Parthenon Wei LiFounding Partner at6 Dimensions Capital Micah MackisonSenior VP for Corporate Development and Strategy atAssembly Biosciences Wendy PanPartner atSidley Donghui QinDirector of Innovation atFerring Pharmaceuticals Greg ScottFounder and Chairman atChinaBIO Group Victor ShiChairman atBayHelix Alan TurleyDeputy Assistant Secretary for China atU.S. Department of Commerce Jonathan WangSenior VP and Head of Business Development atZai Lab Lijun WuChief Scientific Officer and Senior VP R&D, Fosun Pharma USA atFosun Pharma USA Haishan XiongSenior Vice President for Business Development atFountain Medical Development, Ltd GE YanfengDirector-General of the Research Department of Social Development atDevelopment Research Center of the State Council (DRC) Debra YuManaging Director atChina Renaissance Securities (US) Inc.
Interests
, , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , ,